​

P3 Health Partners (PIII) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PIII Stock Forecast

P3 Health Partners (PIII) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $9.00, with a high of $14.00 and a low of $4.00. This represents a -33.63% decline from the last price of $13.56.

- $3 $6 $9 $12 $15 High: $14 Avg: $9 Low: $4 Last Closed Price: $13.56

PIII Stock Rating

P3 Health Partners stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (50.00%), 2 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 2 2 Strong Sell Sell Hold Buy Strong Buy

PIII Price Target Upside V Benchmarks

TypeNameUpside
StockP3 Health Partners-33.63%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks26.90%

Price Target Trends

1M3M12M
# Anlaysts124
Avg Price Target$14.00$9.00$12.63
Last Closing Price$13.56$13.56$13.56
Upside/Downside3.24%-33.63%-6.86%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-11--2
May, 26-11--2
Apr, 26-11--2
Mar, 26-11--2
Feb, 26-11--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 15, 2026UBS$14.00$7.7580.65%3.24%
Mar 27, 2026Ben HaynorLake Street$4.00$2.9436.05%-70.50%
Nov 17, 2025Lake Street$12.50$6.3696.54%-7.82%
Aug 28, 2025Lake Street$20.00$8.32140.38%47.49%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 22, 2026Cowen & Co.HoldHoldhold
May 15, 2026Lake StreetBuyBuyhold
Mar 27, 2026Lake StreetBuyBuyhold
Apr 01, 2024BTIGNeutraldowngrade
Jan 12, 2023William BlairOutperformOutperformhold

Financial Forecast

EPS Forecast

$-350 $-280 $-210 $-140 $-70 $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-188.17$-324.84$-30.44$-46.79$-45.26-
Avg Forecast$-0.77$-5.14$-0.74$-0.56$-0.40$-0.42
High Forecast$-0.75$-4.85$-0.68$-0.52$-0.37$-0.39
Low Forecast$-0.79$-5.47$-0.81$-0.61$-0.44$-0.46
Surprise %24337.66%6219.84%4013.51%8255.36%11215.00%-

Revenue Forecast

$500M $800M $1B $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$637.36M$1.05B$1.27B$1.50B$1.46B-
Avg Forecast$642.00M$1.04B$1.22B$1.51B$1.49B$1.67B
High Forecast$653.98M$1.10B$1.31B$1.52B$1.52B$1.79B
Low Forecast$629.60M$998.86M$1.21B$1.42B$1.46B$1.57B
Surprise %-0.72%0.51%3.56%-0.50%-2.10%-

Net Income Forecast

$-2B $-2B $-1B $-800M $-400M $0 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-156.48M$-270.13M$-57.77M$-135.85M$-319.04M-
Avg Forecast$-226.83M$-1.51B$-219.59M$-166.17M$-118.25M$-124.58M
High Forecast$-221.14M$-1.43B$-200.73M$-151.90M$-108.09M$-113.88M
Low Forecast$-232.34M$-1.61B$-238.45M$-180.45M$-128.41M$-135.28M
Surprise %-31.02%-82.15%-73.69%-18.25%169.80%-

PIII Forecast FAQ

Is P3 Health Partners stock a buy?

P3 Health Partners stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that P3 Health Partners is a favorable investment for most analysts.

What is P3 Health Partners's price target?

P3 Health Partners's price target, set by 4 Wall Street analysts, averages $9 over the next 12 months. The price target range spans from $4 at the low end to $14 at the high end, suggesting a potential -33.63% change from the previous closing price of $13.56.

How does P3 Health Partners stock forecast compare to its benchmarks?

P3 Health Partners's stock forecast shows a -33.63% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (26.90%).

What is the breakdown of analyst ratings for P3 Health Partners over the past three months?

  • June 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2026: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is P3 Health Partners’s EPS forecast?

P3 Health Partners's average annual EPS forecast for its fiscal year ending in December 2026 is $-0.42, marking a -99.07% decrease from the reported $-45.26 in 2025..

What is P3 Health Partners’s revenue forecast?

P3 Health Partners's average annual revenue forecast for its fiscal year ending in December 2026 is $1.67B, reflecting a 14.46% increase from the reported $1.46B in 2025.

What is P3 Health Partners’s net income forecast?

P3 Health Partners's net income forecast for the fiscal year ending in December 2026 stands at $-125M, representing a -60.95% decrease from the reported $-319M in 2025.